Cosmo Pharmaceuticals N.V.
Cosmo Pharmaceuticals N.V. (CMOPF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · CMOPF · as of Jun 8, 2026
Key Statistics
Explore Cosmo Pharmaceuticals N.V. Data
cmopf stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 1 · Buy rate: 100.0%
Competitors & Peers
cmopf competitorsCMOPF
CHIZF
EVOTF
GNTLF
KSPHF
LJUIFStock Performance
Full HistoryAbout Cosmo Pharmaceuticals N.V.
Cosmo Pharmaceuticals N.V. a specialty pharmaceutical company, focuses on the development and commercialization products for gastroenterology and endoscopy worldwide. It offers Lialda/Mezavant/Mesava…
what is cosmo pharmaceuticals n.v. · cmopf stock overview · cosmo pharmaceuticals n.v. company profile · who is cosmo pharmaceuticals n.v. ceo · cmopf OTC · cosmo pharmaceuticals n.v. headquarters · cosmo pharmaceuticals n.v. business segments
About Stock Overview & Key Data
Cosmo Pharmaceuticals N.V. (CMOPF) is a Healthcare company in the Drug Manufacturers - Specialty & Generic industry, listed on OTC since Jul 31, 2017. As of the latest trading session, CMOPF stock price is $90.00, with a market capitalization of $1.5B. The stock has returned +39.82% over the past 12 months and -32.33% year-to-date.
According to 1 Wall Street analysts, the consensus rating for Cosmo Pharmaceuticals N.V. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Cosmo Pharmaceuticals N.V. reported revenue of $104.8M and net income of -$3.6M. For detailed data — including Cosmo Pharmaceuticals N.V. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Cosmo Pharmaceuticals N.V. (CMOPF) stock price is $90.00. The stock is traded on OTC under the ticker symbol CMOPF. The 52-week range is $64.37 – $169.90.